Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model

Abstract

Our findings support adding a second varicella vaccine dose in Turkey, as doing so is highly cost-effective across a wide range of assumptions regarding the burden associated with varicella and HZ disease.